Dr. Cash is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 S Main St
Fort Worth, TX 76104Phone+1 817-702-1100Fax+1 817-702-2140
Summary
- Dr. Tiyonnoh Cash is a neurologist in Austin, TX and is affiliated currently with Banner Health Clinic-Neurology in Colorado. She received her medical degree from University of Texas Medical Branch School of Medicine and has been in practice 16 years. She specializes in neurophysiology, specifically NCS/EMG testing. She has 5 publications and over 300 citings.
Education & Training
- University of California (Irvine)Fellowship, Clinical Neurophysiology, 2013 - 2014
- University of California (Irvine)Fellowship, Neuromuscular Medicine (Neurology), 2012 - 2013
- University of Vermont Medical CenterResidency, Neurology, 2009 - 2012
- William Beaumont Army Medical CenterInternship, Internal Medicine, 2005 - 2006
- University of Texas Medical Branch School of MedicineClass of 2004
Certifications & Licensure
- CA State Medical License 2012 - 2026
- NH State Medical License 2022 - 2026
- CO State Medical License 2020 - 2025
- MN State Medical License 2016 - 2025
- MO State Medical License 2021 - 2025
- NV State Medical License 2024 - 2025
- SD State Medical License Active through 2025
- American Board of Psychiatry and Neurology Neurology
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsConsistent improvement with eculizumab across muscle groups in myasthenia gravisRenato Mantegazza, Fanny O'Brien, Marcus Yountz, James F. Howard, Claudio Mazia
Annals of Clinical and Translational Neurology. 2020-08-01 - 27 citationsSafety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial.Christopher Grunseich, Ram R. Miller, Therese Swan, David J. Glass, Mohamed El Mouelhi
The Lancet. Neurology. 2018-12-01 - 396 citationsSafety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-bli...James F. Howard, Kimiaki Utsugisawa, Michael Benatar, Hiroyuki Murai, Richard J. Barohn
The Lancet. Neurology. 2017-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: